Environmental Surveillance (ES) for Polio and AMR Using the TaqMan Array Card
NCT03818477 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8500
Last updated 2019-10-03
Summary
This study will be used to develop a tool to streamline poliovirus environmental surveillance for the polio endgame and to provide a tool for detecting polio in places where there is no capacity to carry out the gold standard culture-based detection.
Conditions
Sponsors & Collaborators
-
Bill and Melinda Gates Foundation
collaborator OTHER -
International Centre for Diarrhoeal Disease Research, Bangladesh
collaborator OTHER -
University of Virginia
lead OTHER
Principal Investigators
-
Mami Taniuchi · University of Virginia
Eligibility
- Max Age
- 4 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-06-09
- Primary Completion
- 2020-02-28
- Completion
- 2020-09-30
Countries
- Bangladesh
Study Locations
More Related Trials
-
Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine
NCT02291263 ·Status: COMPLETED ·Phase: PHASE3
-
Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study
NCT03722004 ·Status: COMPLETED ·Phase: PHASE4
-
Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh
NCT05644184 ·Status: RECRUITING ·Phase: PHASE2
-
Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study
NCT02847026 ·Status: COMPLETED ·Phase: PHASE4
-
Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh
NCT01375647 ·Status: COMPLETED ·Phase: PHASE3
-
Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules
NCT02412514 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults
NCT03430349 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity of Inactivated and Live Polio Vaccines
NCT01813604 ·Status: COMPLETED ·Phase: PHASE3
-
ROTATEQ Reexamination Study (V260-037)
NCT01074242 ·Status: COMPLETED
-
Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants
NCT05033561 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
NCT02062385 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine
NCT02643368 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV
NCT06114810 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania
NCT02582255 ·Status: COMPLETED ·Phase: PHASE4
-
Duration of IPV Priming and Antibody Decay
NCT03202719 ·Status: COMPLETED ·Phase: PHASE4
-
Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
NCT01571505 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027)
NCT00836498 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Buffer on Immune Response to Oral Polio Vaccine (OPV) in Bangladesh
NCT01579825 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
NCT06592794 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab
NCT00737503 ·Status: COMPLETED ·Phase: PHASE4
-
Etiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia
NCT06363890 ·Status: RECRUITING
-
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
NCT01177657 ·Status: COMPLETED
-
Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)
NCT00496054 ·Status: COMPLETED ·Phase: PHASE3
-
Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India
NCT03554213 ·Status: COMPLETED
-
A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea
NCT01274897 ·Status: COMPLETED ·Phase: PHASE3